Total Payments
$107,049
2024 Payments
$194.17
Companies
15
Transactions
152
Medicare Patients
1,585
Medicare Billing
$195,356
Payment Breakdown by Category
Other$91,590 (85.6%)
Consulting$7,730 (7.2%)
Food & Beverage$3,656 (3.4%)
Travel$3,551 (3.3%)
Education$522.88 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $91,590 | 42 | 85.6% |
| Consulting Fee | $7,730 | 8 | 7.2% |
| Food and Beverage | $3,656 | 72 | 3.4% |
| Travel and Lodging | $3,551 | 12 | 3.3% |
| Education | $522.88 | 18 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $72,414 | 74 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $18,449 | 22 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $6,218 | 6 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, INC. | $5,021 | 10 | $0 (2018) |
| PFIZER INC. | $3,742 | 11 | $0 (2023) |
| Servier Pharmaceuticals LLC | $318.52 | 8 | $0 (2021) |
| BTG INTERNATIONAL, INC. | $148.08 | 7 | $0 (2020) |
| Novo Nordisk Inc | $123.99 | 1 | $0 (2022) |
| SOBI, INC | $119.21 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $115.25 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $194.17 | 2 | SOBI, INC ($119.21) |
| 2023 | $135.07 | 6 | Janssen Biotech, Inc. ($46.68) |
| 2022 | $16,437 | 10 | Janssen Pharmaceuticals, Inc ($13,538) |
| 2021 | $8,097 | 17 | Janssen Pharmaceuticals, Inc ($4,511) |
| 2020 | $12,441 | 16 | E.R. Squibb & Sons, L.L.C. ($5,637) |
| 2019 | $19,999 | 22 | Janssen Pharmaceuticals, Inc ($16,618) |
| 2018 | $31,450 | 53 | Janssen Pharmaceuticals, Inc ($20,840) |
| 2017 | $18,297 | 26 | Janssen Pharmaceuticals, Inc ($13,606) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $119.21 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/07/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $74.96 | General |
| Category: Oncology | ||||||
| 09/13/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Rare Disease | ||||||
| 09/09/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug), LUTATHERA | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Oncology | ||||||
| 05/17/2023 | Janssen Biotech, Inc. | DARZALEX (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Oncology | ||||||
| 04/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/29/2023 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Oncology | ||||||
| 03/10/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.44 | General |
| 09/29/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,960.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,465.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $40.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $123.99 | General |
| Category: Diabetes | ||||||
| 03/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,465.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/02/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,775.00 | General |
| Category: Oncology | ||||||
| 12/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/02/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Education | In-kind items and services | $48.35 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Education | In-kind items and services | $48.35 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2021 | Servier Pharmaceuticals LLC | TIBSOVO (Drug) | Education | In-kind items and services | $31.28 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 444 | 499 | $217,474 | $51,375 |
| 2022 | 6 | 369 | 423 | $190,710 | $47,644 |
| 2021 | 5 | 398 | 462 | $209,902 | $53,684 |
| 2020 | 6 | 374 | 399 | $167,852 | $42,654 |
Total Patients
1,585
Total Services
1,783
Medicare Billing
$195,356
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 165 | 179 | $111,159 | $24,303 | 21.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 135 | 145 | $60,900 | $14,825 | 24.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 42 | 54 | $17,226 | $5,051 | 29.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 65 | $14,365 | $4,040 | 28.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 36 | 37 | $11,544 | $2,414 | 20.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 19 | $2,280 | $741.76 | 32.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 166 | 186 | $115,506 | $28,730 | 24.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 96 | $30,624 | $7,694 | 25.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 66 | 69 | $28,980 | $7,286 | 25.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 48 | $10,608 | $2,675 | 25.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $3,432 | $865.25 | 25.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 13 | $1,560 | $393.86 | 25.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 194 | 220 | $136,620 | $34,885 | 25.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 90 | 116 | $37,004 | $9,488 | 25.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 51 | 51 | $21,420 | $5,492 | 25.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 58 | $12,818 | $3,301 | 25.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 17 | $2,040 | $517.31 | 25.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 125 | 130 | $80,730 | $20,277 | 25.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 104 | 108 | $45,360 | $11,466 | 25.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 57 | 65 | $20,735 | $5,453 | 26.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 32 | 39 | $8,619 | $2,285 | 26.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 28 | 29 | $9,048 | $2,283 | 25.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 28 | 28 | $3,360 | $890.68 | 26.5% |
About Dr. Daniel Forman, DO
Dr. Daniel Forman, DO is a Hematology & Oncology healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780633941.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Forman, DO has received a total of $107,049 in payments from pharmaceutical and medical device companies, with $194.17 received in 2024. These payments were reported across 152 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($91,590).
As a Medicare-enrolled provider, Forman has provided services to 1,585 Medicare beneficiaries, totaling 1,783 services with total Medicare billing of $195,356. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Lancaster, PA
- Active Since 05/08/2006
- Last Updated 07/10/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1780633941
Products in Payments
- XARELTO (Drug) $72,414
- ELIQUIS (Drug) $21,877
- BEVYXXA (Drug) $5,021
- IMFINZI (Drug) $3,420
- IMFINZI (Biological) $2,775
- TIBSOVO (Drug) $318.52
- VORAXAZE (Drug) $148.08
- Ozempic (Drug) $123.99
- VONJO (Drug) $119.21
- OSTEOCOOL RF ABLATION (Device) $101.70
- KRAZATI (Drug) $74.96
- SOLIRIS (Drug) $73.95
- IMBRUVICA (Drug) $59.99
- KISQALI (Drug) $55.63
- TECVAYLI (Biological) $26.96
- TAGRISSO (Drug) $22.72
- ADCETRIS (Biological) $21.98
- DARZALEX (Drug) $19.72
- PLUVICTO (Drug) $19.66
- ULTOMIRIS (Biological) $18.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lancaster
Niyati Nathwani, M.d, M.D
Hematology & Oncology — Payments: $35,518
Hematology & Oncology $35,518
Lena Dumasia, Md, MD
Hematology & Oncology — Payments: $10,348
Hematology & Oncology $10,348
Neha Patil, Md, MD
Hematology & Oncology — Payments: $7,061
Hematology & Oncology $7,061
Shanthi Sivendran, M.d, M.D
Hematology & Oncology — Payments: $6,966
Hematology & Oncology $6,966
Hyatt Degreen, D.o, D.O
Hematology & Oncology — Payments: $5,691
Hematology & Oncology $5,691
Dr. Amartej Merla, Md, MD
Hematology & Oncology — Payments: $5,401
Hematology & Oncology $5,401